Previous close | 33.20 |
Open | 37.27 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 600.00 |
Expiry date | 2023-06-16 |
Day's range | 30.39 - 38.00 |
Contract range | N/A |
Volume | |
Open interest | N/A |
On the call with me today is Marc Casper, our chairman, president, and chief executive officer; and Stephen Williamson, senior vice president, and chief financial officer. A copy of the press release of our fourth quarter and full year 2022 earnings is available in the Investors section of our website under the heading Financials.
Robust year-over-year growth in the Analytical Instruments and the Laboratory Products and Biopharma Services segments boost Thermo Fisher's (TMO) Q4 revenues.
Although the revenue and EPS for Thermo Fisher (TMO) give a sense of how its business performed in the quarter ended December 2022, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.